Mokam Life Science Research Institute Relocates to Seocho-gu, Seoul... "Strengthening AI Drug Development Research"

[Asia Economy Reporter Lee Gwan-joo] Mokam Life Science Research Institute announced on the 13th that it has relocated its research institute from Yongin-si, Gyeonggi Province to Seocho-gu, Seoul.

The institute explained that this move is aimed at strengthening AI-based new drug development research. Being close to Gangnam and Pangyo, where AI-related companies are concentrated, it is expected to facilitate the recruitment of excellent talent in the field.

A representative of Mokam Research Institute said, "AI-based new drug development is a field that integrates various academic disciplines and is becoming a global trend. It is important to discover and nurture outstanding talents who will devote themselves to research." He added, "Using the relocation as a stepping stone, we plan to secure excellent research personnel and strengthen business capabilities to create a new paradigm in AI drug development."

Established in 1984, Mokam Research Institute developed the world's first epidemic hemorrhagic fever vaccine and influenza vaccine, among other biopharmaceuticals. Since last year, it has ventured into AI-utilized new drug development research, currently focusing on mRNA (messenger ribonucleic acid) and recombinant protein studies.

This content was produced with the assistance of AI translation services.